213 related articles for article (PubMed ID: 10813869)
1. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
[TBL] [Abstract][Full Text] [Related]
2. Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy (Review).
Selvakumar P; Pasha MK; Ashakumary L; Dimmock JR; Sharma RK
Int J Mol Med; 2002 Oct; 10(4):493-500. PubMed ID: 12239600
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
4. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
5. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
6. Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.
Shrivastav A; Sharma AR; Bajaj G; Charavaryamath C; Ezzat W; Spafford P; Gore-Hickman R; Singh B; Copete MA; Sharma RK
Oncol Rep; 2007 Jul; 18(1):93-7. PubMed ID: 17549352
[TBL] [Abstract][Full Text] [Related]
7. Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29.
Selvakumar P; Lakshmikuttyamma A; Lawman Z; Bonham K; Dimmock JR; Sharma RK
Biochem Biophys Res Commun; 2004 Sep; 322(3):1012-7. PubMed ID: 15336565
[TBL] [Abstract][Full Text] [Related]
8. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
9. Regulation of N-myristoyltransferase by novel inhibitor proteins.
Shrivastav A; Selvakumar P; Bajaj G; Lu Y; Dimmock JR; Sharma RK
Cell Biochem Biophys; 2005; 43(1):189-202. PubMed ID: 16043893
[TBL] [Abstract][Full Text] [Related]
10. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
Kim YW; Park YK; Yoon TY; Lee SM
Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
[TBL] [Abstract][Full Text] [Related]
12. Potential role of N-myristoyltransferase in cancer.
Selvakumar P; Lakshmikuttyamma A; Shrivastav A; Das SB; Dimmock JR; Sharma RK
Prog Lipid Res; 2007 Jan; 46(1):1-36. PubMed ID: 16846646
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells.
Shrivastav A; Varma S; Senger A; Khandelwal RL; Carlsen S; Sharma RK
J Pathol; 2009 Jul; 218(3):391-8. PubMed ID: 19360752
[TBL] [Abstract][Full Text] [Related]
14. [P53 gene mutation in gallbladder cancer].
Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X
Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865
[TBL] [Abstract][Full Text] [Related]
15. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
17. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
18. [p53 and p27 gene expression in subserosal gallbladder carcinoma].
Roa E I; Lantadilla H S; Ibacache S G; de Aretxabala U X
Rev Med Chil; 2009 Aug; 137(8):1017-22. PubMed ID: 19915764
[TBL] [Abstract][Full Text] [Related]
19. N-myristoyltransferase 2 expression in human colon cancer: cross-talk between the calpain and caspase system.
Selvakumar P; Smith-Windsor E; Bonham K; Sharma RK
FEBS Lett; 2006 Apr; 580(8):2021-6. PubMed ID: 16530191
[TBL] [Abstract][Full Text] [Related]
20. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma.
Wang SN; Chung SC; Tsai KB; Chai CY; Chang WT; Kuo KK; Chen JS; Lee KT
Kaohsiung J Med Sci; 2006 Feb; 22(2):53-9. PubMed ID: 16568721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
